Regulation of transthyretin by thyroid hormones in fish. | - CCMAR -

Journal Article

TítuloRegulation of transthyretin by thyroid hormones in fish.
Publication TypeJournal Article
AuthorsMorgado, I, Santos, CRA, Jacinto, R, Power, DM
Year of Publication2007
JournalGen Comp Endocrinol
Date Published2007 Jun-Jul
Palavras-chaveAnimals, Antibodies, Antibody Specificity, Antithyroid Agents, Blood Proteins, Blotting, Western, Enzyme-Linked Immunosorbent Assay, Female, Liver, Methimazole, Prealbumin, Rabbits, RNA, Messenger, Sea Bream, Thyroxine, Transcription, Genetic, Triiodothyronine

Transthyretin (TTR) is a thyroid hormone-binding protein (THBP) which in its tetrameric form transports thyroid hormones (THs), thyroxine (T(4)) and triiodothyronine (T(3)) in the blood of vertebrates. The principal site of production of TTR is the liver but in the sea bream TTR mRNA is also present in the heart, intestine and brain. The regulation of TTR is unstudied in fish and the normal circulating level of this THBP is unknown. The aim of the present study was to establish factors which regulate TTR production in fish. As a first step a number of tools were generated; sea bream recombinant TTR (sbrTTR) and specific sbrTTR antisera which were used to establish an ELISA (enzyme-linked immunosorbent assay) for measuring TTR plasma levels. Subsequently, an experiment was conducted to determine the influence of THs on TTR production. Circulating physiological levels of TTR in sea bream determined by ELISA are approximately 3.8microgml(-1). Administration of T(3) and T(4) to sea bream significantly increased (p<0.001 and p<0.005, respectively) the concentration of circulating TTR ( approximately or = 11.5microgml(-1)) in relation to control fish, but did not change gene transcription in the liver. Methimazol (MMI) an antithyroid agent, failed to significantly reduce circulating THs below control levels but significantly increased (p<0.005) plasma TTR levels (approximately or = 10.8microgml(-1)) and decreased (p<0.05) transcription in the liver. Future studies will aim to elucidate in more detail these regulatory pathways.


Alternate JournalGen. Comp. Endocrinol.
PubMed ID17289043
CCMAR Authors